Khaled A. Khaled

642 total citations
17 papers, 537 citations indexed

About

Khaled A. Khaled is a scholar working on Pharmaceutical Science, Immunology and Molecular Biology. According to data from OpenAlex, Khaled A. Khaled has authored 17 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Khaled A. Khaled's work include Advanced Drug Delivery Systems (7 papers), Drug Solubulity and Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (3 papers). Khaled A. Khaled is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Drug Solubulity and Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (3 papers). Khaled A. Khaled collaborates with scholars based in Egypt, Japan and Saudi Arabia. Khaled A. Khaled's co-authors include Yousry M. El‐Sayed, Amal K. Hussein, Zeinab Fathalla, Raid G. Alany, A. Vangala, Yousif A. Asiri, Omar H. El-Garhy, Fatma M. Mady, Hatem A. Sarhan and Youssef W. Naguib and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Fertility and Sterility.

In The Last Decade

Khaled A. Khaled

17 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled A. Khaled Egypt 10 282 107 83 79 52 17 537
Rajesh Kesarla India 8 354 1.3× 154 1.4× 68 0.8× 46 0.6× 48 0.9× 10 579
Sajeev Chandran India 14 358 1.3× 80 0.7× 66 0.8× 92 1.2× 27 0.5× 24 653
Hazem Ali United States 10 239 0.8× 109 1.0× 76 0.9× 36 0.5× 50 1.0× 10 465
Gehan F. Balata Egypt 13 316 1.1× 105 1.0× 88 1.1× 32 0.4× 50 1.0× 30 527
Müzeyyen Demirel Türkiye 13 271 1.0× 82 0.8× 50 0.6× 54 0.7× 49 0.9× 21 418
Kok-Khiang Peh Malaysia 13 335 1.2× 119 1.1× 69 0.8× 25 0.3× 69 1.3× 21 630
Shadeed Gad Egypt 15 408 1.4× 127 1.2× 90 1.1× 28 0.4× 34 0.7× 71 624
Swati Pund India 11 368 1.3× 121 1.1× 68 0.8× 32 0.4× 32 0.6× 18 562
Katja Berginc Slovenia 15 240 0.9× 121 1.1× 41 0.5× 30 0.4× 64 1.2× 28 601

Countries citing papers authored by Khaled A. Khaled

Since Specialization
Citations

This map shows the geographic impact of Khaled A. Khaled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled A. Khaled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled A. Khaled more than expected).

Fields of papers citing papers by Khaled A. Khaled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled A. Khaled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled A. Khaled. The network helps show where Khaled A. Khaled may publish in the future.

Co-authorship network of co-authors of Khaled A. Khaled

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled A. Khaled. A scholar is included among the top collaborators of Khaled A. Khaled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled A. Khaled. Khaled A. Khaled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shimizu, Taro, Hidenori Ando, Mohamed Abbas Ibrahim, et al.. (2024). Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice. Molecular Pharmaceutics. 21(2). 622–632. 8 indexed citations
2.
Shimizu, Taro, Hidenori Ando, Sherif E. Emam, et al.. (2023). Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives. Journal of Pharmaceutical Sciences. 113(3). 555–578. 24 indexed citations
3.
Abdelrahman, Ahmed A., et al.. (2021). Therapeutic Impacts of Hyperbaric Oxygen Therapy and Risperidone on Children with Autism: A Clinical Trial. Basic and Clinical Neuroscience Journal. 14(4). 501–510. 2 indexed citations
4.
Shimizu, Taro, Nehal E. Elsadek, Sherif E. Emam, et al.. (2021). Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice. Molecular Pharmaceutics. 18(6). 2406–2415. 8 indexed citations
5.
Alaaeldin, Eman, Amr S. Abu Lila, Hidenori Ando, et al.. (2017). Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules. Journal of Controlled Release. 255. 210–217. 7 indexed citations
6.
Fathalla, Zeinab, A. Vangala, Khaled A. Khaled, et al.. (2017). Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. European Journal of Pharmaceutics and Biopharmaceutics. 114. 119–134. 139 indexed citations
7.
Fathalla, Zeinab, Khaled A. Khaled, Amal K. Hussein, Raid G. Alany, & A. Vangala. (2015). Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles. Drug Development and Industrial Pharmacy. 42(4). 514–524. 42 indexed citations
8.
Alaaeldin, Eman, Amr S. Abu Lila, Hatem A. Sarhan, et al.. (2013). The Co-Delivery of Oxaliplatin Abrogates the Immunogenic Response to PEGylated siRNA-Lipoplex. Pharmaceutical Research. 30(9). 2344–2354. 14 indexed citations
9.
Hussein, Amal K., et al.. (2013). Meloxicam Depot Parenteral Bio-Degradable Microspheres: Preparation, Characterization and In-Vivo Evaluation. 5 indexed citations
10.
Khaled, Khaled A., et al.. (2010). Prednisolone-Loaded PLGA Microspheres. In Vitro Characterization and In Vivo Application in Adjuvant-Induced Arthritis in Mice. AAPS PharmSciTech. 11(2). 859–869. 38 indexed citations
11.
Mady, Fatma M., Khaled A. Khaled, Keishi Yamasaki, et al.. (2010). Enhancement of the Aqueous Solubility and Masking the Bitter Taste of Famotidine Using Drug/SBE-β-CyD/Povidone K30 Complexation Approach. Journal of Pharmaceutical Sciences. 99(10). 4285–4294. 33 indexed citations
12.
Mady, Fatma M., Khaled A. Khaled, Keishi Yamasaki, et al.. (2010). Evaluation of carboxymethyl-β-cyclodextrin with acid function: Improvement of chemical stability, oral bioavailability and bitter taste of famotidine. International Journal of Pharmaceutics. 397(1-2). 1–8. 44 indexed citations
13.
Darwish, Atef, et al.. (2008). Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia. Fertility and Sterility. 90(5). 1864–1868. 9 indexed citations
14.
Khaled, Khaled A., Hatem A. Sarhan, Mohamed Abbas Ibrahim, & Youssef W. Naguib. (2008). CONTROLLED-RELEASE PREDNISOLONE POLY (DL-LACTIDE) MICROSPHERES: IMPACT OF FORMULATION PARAMETERS, CHARACTERIZATION AND RELEASE MECHANISM. Bulletin of Pharmaceutical Sciences Assiut. 31(1). 49–67. 2 indexed citations
15.
Khaled, Khaled A., et al.. (2003). Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral Doses. Drug Development and Industrial Pharmacy. 29(4). 397–403. 93 indexed citations
16.
Khaled, Khaled A., Yousif A. Asiri, & Yousry M. El‐Sayed. (2001). In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs. International Journal of Pharmaceutics. 222(1). 1–6. 66 indexed citations
17.
Khaled, Khaled A. & Yousry M. El‐Sayed. (2000). HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF QUERCETIN IN PLASMA. Journal of Liquid Chromatography & Related Technologies. 23(3). 455–465. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh Kesarla Breakdown of academic impact, for papers by Sajeev Chandran Breakdown of academic impact, for papers by Hazem Ali Breakdown of academic impact, for papers by Gehan F. Balata Breakdown of academic impact, for papers by Müzeyyen Demirel Breakdown of academic impact, for papers by Kok-Khiang Peh Breakdown of academic impact, for papers by Shadeed Gad Breakdown of academic impact, for papers by Swati Pund Breakdown of academic impact, for papers by Katja Berginc
Rankless by CCL
2026